Literature DB >> 8635248

Structure and characterization of the 5'-flanking region of the mouse smooth muscle myosin heavy chain (SM1/2) gene.

M Watanabe1, Y Sakomura, M Kurabayashi, I Manabe, M Aikawa, M Kuro-o, T Suzuki, Y Yazaki, R Nagai.   

Abstract

We have previously shown that smooth muscle myosin heavy chain isoforms (SMs), including SM1, SM2, and SMemb, are differentially expressed during vascular development, and in vascular lesions, such as atherosclerosis. The SM1/2 gene is expressed exclusively in smooth muscle cells and generates SM1 and SM2 mRNAs by alternative splicing. Whereas SM1 is constitutively expressed from early development, SM2 appears only after birth. In this study, we have isolated and characterized the 5'-flanking region of the mouse SM1/2 gene. Transient transfection assays using a series of promoter-luciferase chimeric constructs demonstrated that tandem elements of the CCTCCC sequence, located at -89 and -61 bp relative to the transcription start site, were essential for transcriptional activity of the SM1/2 gene in primary cultured rabbit aortic smooth muscle cells and smooth muscle cell lines derived from the rabbit aorta but not in non-smooth muscle cells. Gel mobility shift assays indicated that CCTCCC was a binding site for nuclear proteins prepared from smooth muscle cells. Double-stranded oligonucleotides containing either the CACC box or the Sp1 consensus sequence efficiently competed with the CCTCCC elements for binding the nuclear extracts. Site-specific mutations of CCTCCC elements resulted in a significant reduction of the promoter activity. Moreover, CCTCCC elements are evolutionary conserved between mouse and rabbit. In conclusion, the results of this study indicate an important role for the interaction of the CCTCCC sequence with Sp1 or related factors in activating transcription from the SM1/2 gene promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635248     DOI: 10.1161/01.res.78.6.978

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

1.  A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer.

Authors:  C E Appleby; P A Kingston; A David; C A Gerdes; P Umaña; M G Castro; P R Lowenstein; A M Heagerty
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

Review 2.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation.

Authors:  K Sobue; K Hayashi; W Nishida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo.

Authors:  I Manabe; G K Owens
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

4.  Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats.

Authors:  Karen M Martin; Peter D Ellis; James C Metcalfe; Paul R Kemp
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

5.  Conversion from mouse embryonic to extra-embryonic endoderm stem cells reveals distinct differentiation capacities of pluripotent stem cell states.

Authors:  Lily T Y Cho; Sissy E Wamaitha; Isheng J Tsai; Jérôme Artus; Richard I Sherwood; Roger A Pedersen; Anna-Katerina Hadjantonakis; Kathy K Niakan
Journal:  Development       Date:  2012-07-12       Impact factor: 6.868

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.